Clinical trialNCT06878261RecruitingPhase 3Interventional

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

SponsorAstraZenecaEnrollment990Chronic Obstructive Pulmonary Disease (COPD)

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

MeiLan Han, MD
University of Michigan Health, Pulmonary & Critical Care Medicine,
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

268 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Research Site
Alberdi, Argentina
Recruiting
Research Site
Buenos Aires, Argentina
Recruiting
Research Site
Ciudad de Buenos Aires, Argentina
Recruiting
Research Site
Florida, Argentina
Recruiting
Research Site
La Plata, Argentina
Recruiting
Research Site
La Plata, Argentina
Recruiting
Research Site
Mar del Plata, Argentina
Recruiting
Research Site
Mendoza, Argentina
Recruiting
Research Site
Quilmes, Argentina
Recruiting
Research Site
Rosario, Argentina
Recruiting
Research Site
San Fernando, Argentina
Recruiting
Research Site
San Juan Bautista, Argentina
Recruiting

Australia

Research Site
Coffs Harbour, Australia
Recruiting
Research Site
Frankston, Australia
Recruiting
Research Site
Garran, Australia
Withdrawn
Research Site
Nedlands, Australia
Recruiting
Research Site
New Lambton, Australia
Recruiting
Research Site
Spearwood, Australia
Recruiting
Research Site
Wollongong, Australia
Withdrawn
Research Site
Woodville South, Australia
Recruiting

Belgium

Research Site
Genk, Belgium
Recruiting
Research Site
Ghent, Belgium
Recruiting
Research Site
Jette, Belgium
Recruiting
Research Site
Leuven, Belgium
Recruiting
Research Site
Mechelen, Belgium
Recruiting
Research Site
Namur, Belgium
Recruiting

Bulgaria

Research Site
Dupnitsa, Bulgaria
Recruiting
Research Site
Haskovo, Bulgaria
Recruiting
Research Site
Lovech, Bulgaria
Withdrawn
Research Site
Pleven, Bulgaria
Recruiting
Research Site
Plovdiv, Bulgaria
Recruiting
Research Site
Rousse, Bulgaria
Withdrawn
Research Site
Rousse, Bulgaria
Recruiting
Research Site
Sofia, Bulgaria
Recruiting
Research Site
Sofia, Bulgaria
Withdrawn
Research Site
Sofia, Bulgaria
Recruiting
Research Site
Sofia, Bulgaria
Recruiting
Research Site
Stara Zagora, Bulgaria
Recruiting
Research Site
Varna, Bulgaria
Withdrawn
Research Site
Veliko Tanovo, Bulgaria
Recruiting

228 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 25 Mar 2025
Primary completion: 13 Mar 2029
Completion: 5 Jun 2029
Last update posted: 24 Jun 2026
Registered enrollment: 990
Registry id: NCT06878261

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.